Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)
Inari Medical(NARI.US) Director Sells US$3.4 Million in Common Stock
$Inari Medical(NARI.US)$ Director Hoffman William sold 60,000 shares of common stock on Jul 16, 2024 at an average price of $56.74 for a total value of $3.4 million.Source: Announcement What is
Inari Medical Insider Sold Shares Worth $3,404,646, According to a Recent SEC Filing
William Hoffman, Director, on July 16, 2024, sold 60,000 shares in Inari Medical (NARI) for $3,404,646. Following the Form 4 filing with the SEC, Hoffman has control over a total of 743,296 shares
Needham Cuts Inari to Hold, Cites Competitive Concerns
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Express News | Inari Medical Shares Are Trading Lower After Needham Downgraded the Stock From Buy to Hold
Needham Downgrades Inari Medical to Hold From Buy
Inari Medical (NARI) has an average outperform rating and a price target range of $50 to $86, according to analysts polled by Capital IQ.
Express News | Inari Medical Inc : Needham Cuts to Hold From Buy
Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)
Form 144 | Inari Medical(NARI.US) Director Proposes to Sell 5.48 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 16, $Inari Medical(NARI.US)$ Director WILLIAM HOFFMAN intends to sell 100K shares of its common stock on Jul 16, with a total market value of approximately $5.48 million.
Inari Medical to Announce Second Quarter 2024 Financial Results
Truist Financial Maintains Inari Medical(NARI.US) With Hold Rating, Raises Target Price to $60
Truist Financial analyst Richard Newitter maintains $Inari Medical(NARI.US)$ with a hold rating, and adjusts the target price from $47 to $60.According to TipRanks data, the analyst has a success
Truist Securities Maintains Hold on Inari Medical, Raises Price Target to $60
Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and raises the price target from $47 to $60.
Inari Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 9.49% Truist Securities $47 → $60 Maintains Hold 05/01/2024 0.36% Canaccord Genuity $75 → $55
Express News | Inari Medical Inc : Truist Securities Raises Target Price to $60 From $47
Express News | Inari Medical Inc : Morgan Stanley Raises Target Price to $60.00 From $55.00
Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating
Inari Medical (NARI) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $47 to $86.
Inari Medical(NARI.US) Director Sells US$1 Million in Common Stock
$Inari Medical(NARI.US)$ Director Hoffman William sold 20,000 shares of common stock on Jul 1, 2024 at an average price of $50.15 for a total value of $1 million.Source: Announcement What is statement
Inari Medical(NARI.US) Officer Sells US$150.24K in Common Stock
$Inari Medical(NARI.US)$ Officer Hykes Andrew sold 3,000 shares of common stock on Jul 1, 2024 at an average price of $50.08 for a total value of $150.24K.Source: Announcement What is statement of cha
Form 144 | Inari Medical(NARI.US) Director Proposes to Sell 433.35K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Inari Medical(NARI.US)$ Director ANDREW J HYKES intends to sell 9,000 shares of its common stock on Jul 1, with a total market value of approximately $433.35K. ANDREW